Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
William D. Haydon was terminated as Senior Vice President and General Manager, Pain Franchise at AVANOS MEDICAL, INC..
- Action
- terminated
- Role
- Senior Vice President and General Manager, Pain Franchise
Exact text from the filing
On January 10, 2023, the Company and William D. Haydon, the Company’s Senior Vice President and General Manager, Pain Franchise, entered into a Severance and Separation Agreement (the “Severance and Separation Agreement”) pursuant to which: (i) Mr. Haydon’s employment with the Company will terminate effective March 31, 2023 (the “Separation Date”);
View on SEC.gov
Restructurings & Charges
SEC 8-K Item 2.05/2.06
confidence 0.7
AVANOS MEDICAL, INC. announced a restructuring affecting Chronic Care and Pain franchises combined into single commercial organization; exit certain low-margin, low-growth product categories.
- Type
- restructuring
- Affected area
- Chronic Care and Pain franchises combined into single commercial organization; exit certain low-margin, low-growth product categories
Exact text from the filing
On January 10, 2023, Avanos Medical, Inc. (the “Company”) approved a three-year transformation process (the “Transformation Process”) pursuant to which the Company plans to: (i) combine its Chronic Care and Pain franchises into a single commercial organization focused on the Digestive Health and Orthopedic Pain & Recovery product categories; (ii) exit certain low-margin, low-growth product categories, including through targeted divestitures; (iii) undertake additional cost management activities to enhance the Company’s operating profitability; and (iv) pursue efficient capital allocation strategies, including through acquisitions that meet the Company’s strategic and financial criteria.
View on SEC.gov